Are Patients on Cyclophosphamide at Higher Risk of Covid-19 Complications?
L. Preethi, G. Asvitha, S. Ankul Singh, Sarvesh Sabarathinam
International Journal of Pathogen Research · pp. 40–43 · Published 2 Jul 2021
10.9734/ijpr/2021/v7i230179Abstract
Coronaviruses are closely related virus causing several types of respiratory tract infections ranging from common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS) and severe acute respiratory syndrome (SARS). There are many other ways in which Covid-19 will impact the existing public health issues. With the rising number of covid19 cases, it has been reported that people with the weaker immune system are at higher risk. We identified the mechanism of action of cyclophosphamide and its impact on the lung. Pulmonary side effects associated with cyclophosphamide are rare and dose-related. They manifest as early-onset pneumonitis, in patients with symptoms especially like cough and dyspnea. Acrolein in cyclophosphamide is the main component linked with the toxic effect. We hypothesize that use of cyclophosphamide, an antineoplastic agent and immunosuppressive agent used in treating many cancers and autoimmune disorders (like rheumatoid arthritis and ANCA vasculitis), induces severe lung toxicity which can be one of the contributing factors for the increased risk of COVID 19 complication. These factors are to be recognized to improve prevention and control of the disease.
References (7)
- 1 COVID-19: consider cytokine storm syndromes and immunosuppression [DOI]
- 2 Cyclophosphamide Toxicity [DOI]
- 3 Antimalarials for treating rheumatoid arthritis [DOI]
- 4 The 2019 Novel Coronavirus Outbreak: Current Crises, Controversies and Global Strategies to Prevent a Pandemic [DOI]
- 5 A potential role for cyclophosphamide in the mitigation of acute respiratory distress syndrome among patients with SARS-CoV-2 [DOI]
- 6 Attenuation of cyclophosphamide-induced pulmonary toxicity in Swiss albino mice by naphthalimide-based organoselenium compound 2-(5-selenocyanatopentyl)-benzo[de]isoquinoline 1,3-dione [DOI]
- 7 Current Knowledge on the Pathogenesis of and Therapeutic Options against SARS-CoV-2: An Extensive Review of the Available Evidence [DOI]
Cited by 1
1 citation reported by external sources — individual citing-article records aren't available to list yet.
Related research
- Does Pain Adversely Affect the Quality of Life in Hospitalized Cancer Patients? — shares topic coverage
- Complementary Medicine Intervention in Breast Cancer Patients with Pain — shares topic coverage
- Use of Performance Status Score for Cytotoxic Chemotherapy among Surgeons in a Tertiary Hospital, Southern Nigeria — shares topic coverage
- Breast Self Examination and Cancer Awareness among Female Staff in Federal Medical Center, Yenagoa, Bayelsa State (Knowledge and Practice) — shares topic coverage
- Assessment of Cancer Risk from Fluorscopic Bile Duct Examinations at Sanjiwani Hospital, Gianyar — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
1
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.